Minority Stake Acquisitions in Hungary: When They Trigger Merger Control and How to Manage Competition Risks

Minority stake acquisitions Hungary deal teams once treated as low-risk, purely commercial matters now sit squarely within the sights of the Hungarian Competition Authority (GVH) and the country’s foreign direct investment screening regime. Hungary’s FDI framework, combined with the GVH’s active guidance on non-controlling investments, has changed the calculus for in-house counsel, private equity sponsors and cross-border investors. A non-controlling shareholding of 20%, 30% or even less can, in certain fact patterns, be treated as a concentration or attract national-security scrutiny, meaning notification obligations, standstill risks and negotiated remedies.

This article gives deal teams a practical triage: when minority stake acquisitions Hungary regulators will treat as a concentration, how the GVH tests for control, how FDI screening overlaps, and how to draft an SPA that manages the exposure.

Why minority-stake M&A needs special attention in Hungary

The instinct of many deal teams is to assume that anything short of a controlling stake escapes merger control. That assumption is wrong in Hungary, and increasingly costly. The relevant question is not the headline percentage but whether the investor acquires decisive influence over the target. Minority stake acquisitions Hungary counsel routinely encounter, a 25% stake coupled with a veto over the business plan, or a 15% holding with the right to appoint two of five board members, can cross the line into control and therefore into notifiable territory.

Two features have sharpened this risk. First, Hungary’s FDI screening regime captures foreign investors in protected sectors even where they take non-controlling positions. Second, the GVH has continued to apply a substantive, effects-based approach to concentrations, consistent with its guidance and decisional practice published through its official channels. The practical effect is that a single minority transaction can now attract two parallel regulatory workstreams, competition and national security, each with its own trigger, timetable and consequences for closing.

TL;DR decision triage. Before signing any minority deal in Hungary, run three questions:

• Percentage and voting rights. What proportion of shares and votes does the investor acquire, and does that give any structural ability to block or steer decisions?
• Special or reserved rights. Do veto rights, super-majority thresholds, board appointment rights or consent requirements over strategic matters confer decisive influence?
• Coordination and influence. Do shareholders’ agreements, information rights or commercial arrangements enable the investor to coordinate competitive behaviour or influence the target’s market conduct?

If the answer to any of these is “yes” or “maybe”, treat the deal as potentially notifiable and document your analysis. The sections below explain how to work through each limb.

When minority acquisitions trigger GVH merger control

Under Hungarian competition law, merger control bites on a concentration. The threshold question for any minority investor is therefore whether the transaction produces a change of control, not whether it produces a majority. The GVH, whose practice is set out through its published guidance and decisions, assesses control substantively rather than mechanically. This is the single most important principle for minority stake acquisitions Hungary practitioners must internalise: percentages are indicative, but the acquisition of decisive influence is what matters.

Notification triggers: the concentration definition

A concentration arises where an undertaking acquires direct or indirect control over all or part of another undertaking. Control can be sole or joint, and it can rest on rights, contracts or any other means that confer the possibility of exercising decisive influence over an undertaking’s strategic commercial decisions. For minority investors this means that the legal form of the stake is secondary; what counts is whether the package of rights obtained delivers the ability to determine, or to veto, strategic outcomes such as the budget, business plan, senior management appointments or major investments.

Where a concentration exists and the applicable turnover thresholds are met, notification to the GVH becomes mandatory, and completion is subject to a standstill obligation pending clearance. Hungarian merger control minority analysis therefore combines two filters: a qualitative control test and a quantitative turnover test. Both must be satisfied for a mandatory filing to arise. Deal teams should verify the current turnover thresholds against the Hungarian Competition Act and the GVH’s published guidance for each transaction.

Quantitative versus qualitative indicators

Deal teams often want a bright-line percentage. Hungarian law does not offer one for control. Instead, quantitative indicators, the size of the stake, the proportion of voting rights, historic attendance and voting patterns at shareholder meetings, feed into a qualitative judgement about whether decisive influence exists in practice. A large minority stake in a widely dispersed shareholder base may confer de facto control even without any special rights, because the remaining shares are too fragmented to outvote the incoming investor. Conversely, a small stake carrying strong contractual veto rights may confer control that a raw percentage would never suggest.

For minority stake acquisitions Hungary teams should therefore assemble both categories of evidence: the cap table and voting record on one side, and the shareholders’ agreement and reserved-matters schedule on the other. The GVH’s fact-based approach means the drafting of these documents can determine whether a filing is required.

Examples where minority investments were treated as concentrations

Situations that commonly convert a minority stake into a notifiable concentration include: acquisition of a blocking minority combined with the right to appoint or remove key managers; contractual veto rights over the annual budget, business plan or strategic capital expenditure; and de facto control arising where a substantial minority holder faces only a dispersed and passive residual shareholder body. Each of these fact patterns has an analogue in EU practice, and the GVH’s approach is consistent with the decisive-influence standard applied under the EU Merger Regulation and Commission practice. Where the facts are close to the line, the safest course is pre-transaction analysis and, in appropriate cases, informal engagement with the authority.

Legal tests and criteria: how the GVH assesses control in minority stake acquisitions Hungary

The GVH minority stake analysis turns on whether the investor obtains the ability to exercise decisive influence. That test breaks down into de jure control, de facto control, and a careful distinction between protective (minority) rights and rights that amount to genuine control.

De jure control: voting thresholds and rights

De jure control flows from legal rights, typically ownership of a majority of voting shares, or contractual and statutory rights that guarantee the ability to determine strategic decisions. For minority investors, de jure control most often arises through negotiated rights rather than share count: for example, a shareholders’ agreement giving the minority holder a casting vote, a guaranteed majority on the board, or an unconditional right to determine the identity of the CEO. Where such rights are documented and enforceable, the stake will generally be treated as conferring control regardless of the percentage held.

De facto control: board influence, veto and super-majority rights

De facto control is more subtle and more common in minority deals. It arises where, on the facts, the investor is highly likely to be able to exercise decisive influence even without an outright legal guarantee. Indicators include the ability to secure board decisions in practice, veto rights over strategic matters, super-majority provisions that give the minority holder a blocking position on key decisions, and a shareholder base so dispersed that the minority holder effectively controls general meetings. The GVH’s assessment mirrors the Commission’s de facto control analysis under the EU Merger Regulation, which treats the practical ability to block or steer strategic decisions as control-conferring.

Protective rights versus decisive influence

The critical drafting distinction is between protective minority rights, which do not confer control, and rights that give decisive influence, which do. Protective rights are those normally granted to safeguard a minority investor’s financial interest, for example, veto rights over changes to the company’s constitution, changes to share capital that dilute the investor, winding-up, or fundamental changes to the nature of the business. Rights that reach into ordinary strategic and commercial management, vetoes over the business plan, the budget, senior appointments, or significant contracts, tend to cross the line into decisive influence.

Non-controlling investment antitrust Hungary risk therefore lives in the reserved-matters schedule: the more the schedule extends beyond genuine investor protection into operational and strategic control, the greater the likelihood that the GVH will treat the stake as a concentration.

Evidence and the GVH’s fact-pattern analysis

Because the test is substantive, the GVH looks at the whole factual matrix: the constitutional documents, the shareholders’ agreement, board composition, historic voting behaviour, information and consultation rights, and any commercial relationships between the investor and the target. Deal teams should assume that the entire transaction architecture, not just the SPA, will be scrutinised, and should ensure their internal analysis captures each element that could bear on control.

How Hungarian GVH tests for minority-control compare with EU and FDI screening

The following comparison table helps deal teams see, at a glance, how the three regimes that can bite on a Hungarian minority deal differ in their triggers, thresholds and remedies.

The key takeaway is that the competition and FDI regimes ask fundamentally different questions. The GVH and the Commission ask whether the transaction changes who controls the business; FDI screening asks whether a foreign investor’s involvement in a sensitive sector raises national-security or public-order concerns, a question that can be answered “yes” even where no control changes hands.

Interaction with FDI screening, parallel filings and sequencing

For cross-border minority stake acquisitions Hungary now imposes a two-track analysis. Hungary operates two overlapping FDI screening regimes, a general regime and a sector-specific regime for strategic companies, governing the screening of foreign investments on national-security and public-order grounds. Unlike merger control, FDI screening is not premised on the acquisition of control, it can apply to non-controlling foreign investments in protected sectors. This means a foreign investor can face an FDI filing even where the GVH concludes there is no concentration. Deal teams should confirm which regime applies and identify the competent authority for each transaction.

Scope of FDI screening: what triggers review

FDI screening is triggered by the combination of a foreign investor and a target active in a protected or strategic sector. The precise scope of protected sectors and the qualifying investment thresholds are set out in the applicable legislation and implementing decrees as published in Magyar Közlöny, and deal teams should verify the current sector list and thresholds against the official gazette text for each transaction. Because sector definitions and thresholds can be broad, early classification of the target’s activities is essential, a target whose principal business appears benign may nonetheless touch a listed sector through a subsidiary or a discrete line of business.

Overlap and conflicts: simultaneous filings

Where both regimes apply, the two filings run on separate legal bases and separate timetables. A GVH clearance does not resolve an FDI concern, and an FDI approval does not cure a merger-control problem. Deal teams should never assume that clearance under one regime carries across to the other. The two authorities apply different tests, different remedies and different standstill consequences, and either can hold up completion.

Practical sequencing options and timing

There are two broad strategies. Parties can file in parallel, submitting both notifications at or shortly after signing to compress the overall timetable, the usual choice where speed to closing matters. Alternatively, parties can sequence filings, resolving the regime that presents the greater risk first before committing resources to the second. Sequencing can preserve optionality if the first review reveals problems, but it lengthens the critical path. The right choice depends on which regime is more likely to raise substantive issues, and on the parties’ appetite for a longer certain timetable versus a shorter but more uncertain one. Build both filings into the conditions-precedent architecture of the SPA so that completion cannot occur until each required clearance is obtained.

Foreign-investor due diligence checklist

• Investor status. Confirm whether the acquirer qualifies as a foreign investor under the applicable FDI legislation, including through its ultimate beneficial ownership chain.
• Sector classification. Map every activity of the target group against the protected-sector list in the current legislation and decrees.
• Threshold analysis. Verify whether the size of the investment meets the qualifying threshold for screening.
• Parallel merger analysis. Run the GVH control and turnover tests in parallel, so both regimes are assessed before signing.
• Timetable mapping. Model the review phases for both regimes and identify the binding critical path.

Drafting the SPA and investor-side protections to manage GVH risk

The single most effective lever available to deal teams is the drafting itself. Because the GVH’s control assessment turns on the package of rights the investor obtains, careful drafting can keep a genuinely passive minority investment out of merger control, or, where a filing is unavoidable, protect the parties against timing and completion risk. The clauses below are illustrative and should be reviewed against the GVH’s likely factual assessment before use. Drafting SPA minority stake Hungary documents well is a competition-law exercise as much as a corporate one.

Deal structuring to avoid “control”

Where the commercial objective is a purely financial minority position, structure the rights package to stay on the protective side of the line. Techniques include: designing share classes so that the minority holder’s economic and governance rights are separated; limiting reserved matters to genuine investor protections; capping board representation below any level that would deliver decisive influence; and avoiding casting votes or guaranteed management appointments. The narrower and more clearly protective the rights, the stronger the argument that no concentration arises.

Protective or minority rights that create control risk

Certain frequently requested rights carry disproportionate control risk and should be flagged in every deal:

• Veto over the business plan or annual budget. These reach into ordinary strategic management and are among the strongest indicators of decisive influence.
• Right to appoint or remove senior management. Control over the identity of the CEO or key executives points strongly to control.
• Super-majority thresholds on operational decisions. A blocking position over day-to-day strategic matters can confer de facto control.
• Extensive information and consultation rights coupled with commercial links. These can support a finding that the investor influences competitive conduct.

Model clauses (illustrative)

The following clause concepts help manage regulatory exposure and should be adapted and vetted by counsel:

• Notification cooperation clause. An illustrative undertaking by both parties to cooperate in good faith in preparing and submitting any GVH and FDI filings, to share information reasonably required, and to respond promptly to regulator requests.
• Conditional completion. A condition precedent making completion contingent on obtaining all required merger-control and FDI clearances, so the parties cannot close in breach of a standstill obligation.
• Consent and waiver mechanics. Illustrative provisions dealing with how remedy conditions imposed by a regulator are accepted, and which party bears the burden of offering commitments.
• Standstill clause. An undertaking that, pending clearance, the investor will not exercise governance or influence rights that could constitute early implementation of a concentration.
• Hold-separate arrangements. Where sensitive, illustrative measures keeping the businesses operationally separate until clearance.

Negotiation playbook: sellers versus buyers

Buyers generally want maximum governance rights and minimum regulatory delay, an inherent tension, because the rights that deliver influence are precisely those that trigger scrutiny. Sellers want certainty of completion and protection against the deal being unwound or held up. A workable compromise usually allocates filing responsibility and cost, sets a clear long-stop date, defines which party must accept regulator-imposed remedies and up to what threshold, and includes break arrangements if clearances are refused. For minority stake acquisitions Hungary sellers should insist on standstill discipline to avoid gun-jumping exposure that could taint the transaction.

Filing strategy, remedies and likely outcomes for non-controlling stakes

Filing voluntarily versus risking a forced investigation

Where the facts point to possible decisive influence, parties face a choice between filing to obtain legal certainty and proceeding on the view that no concentration arises. Filing where the position is borderline removes the risk of a later enforcement investigation, forced unwinding or fines. Proceeding without filing may be defensible where the analysis is robust and well documented, but it carries residual risk if the GVH later takes a different view of the control facts. In strategic sectors, or where there is prior enforcement activity, early engagement with counsel, and, where appropriate, informal contact with the authority, is prudent.

Typical GVH remedies and behavioural commitments

Where a minority stake is treated as a concentration and raises competitive concerns, the GVH can accept commitments as a condition of clearance. These may be behavioural, for example, undertakings limiting information flows, restricting the exercise of certain governance rights, or ring-fencing competitively sensitive interactions, or structural, such as divestment of overlapping interests. The nature of the remedy depends on the specific competitive risk identified, and remedy design is a negotiation. Deal teams should anticipate the possibility of commitments and allocate, in the SPA, who bears the burden of offering them.

Timeline and fees

Merger review in Hungary proceeds through defined phases, with straightforward cases cleared more quickly than those raising substantive concerns that require an in-depth review. Deal teams should confirm the current review phases and applicable fees against the GVH’s procedural guidance for each transaction, and build the resulting timetable into the SPA’s long-stop date. Because FDI review runs on its own timetable, the binding critical path is whichever clearance takes longest.

Practical red flags in deal documents

• Reserved-matters schedules extending into budgets, business plans and senior appointments.
• Board-appointment rights disproportionate to the equity stake.
• Casting votes, deadlock mechanics that favour the minority, or guaranteed management control.
• Commercial agreements between investor and target that could facilitate coordination.
• Completion mechanics that allow influence to be exercised before clearance.

Case examples and precedents

Because the GVH assesses control substantively, the most instructive precedents are those addressing de facto control and joint ventures, whose reasoning applies directly to minority positions. Analogous fact patterns include: acquisitions of large blocking minorities where a dispersed residual shareholder base gave the incoming investor practical control of general meetings; joint-venture structures where the allocation of veto rights determined whether a party held joint control; and share acquisitions where negotiated governance rights, rather than the headline percentage, drove the finding of decisive influence.

The consistent drafting lesson across these decisions is that the governance package, not the equity figure, determines the regulatory outcome. Practitioners should review the GVH’s published decisions and guidance for the fact patterns closest to their transaction, and where public Hungarian decisions on minority stakes are limited, rely on the Commission’s de facto control practice as persuasive comparative authority.

Conclusion: checklist and next steps

For minority stake acquisitions Hungary now demands a disciplined, two-track regulatory analysis at the earliest stage of every deal. The following ten-point checklist gives in-house teams a repeatable starting point:

1. Run the three-question triage, percentage/voting, special rights, coordination influence.
2. Map the reserved-matters schedule against the protective-rights versus decisive-influence distinction.
3. Assess whether the applicable turnover thresholds are met for a mandatory GVH filing.
4. Classify the target’s activities against the current FDI protected-sector list.
5. Confirm whether the acquirer qualifies as a foreign investor for FDI purposes.
6. Decide on parallel versus sequential filing and build clearances into the conditions precedent.
7. Draft notification-cooperation, conditional-completion, standstill and remedy-allocation clauses.
8. Set a realistic long-stop date reflecting the longest applicable review timetable.
9. Document the control analysis contemporaneously in case the position is later challenged.
10. Engage competition counsel early where the position is borderline or the sector is sensitive.

Handled well, minority stake acquisitions Hungary investors pursue can be structured to preserve commercial objectives while managing merger-control and FDI exposure. For deal-specific advice, connect with an M&A specialist through the Hungary lawyer directory (M&A / Corporate).

Sources

1. Hungarian Competition Authority (GVH)
2. Council Regulation (EC) No 139/2004 (EU Merger Regulation), EUR-Lex
3. European Commission, Mergers and Acquisitions Overview (DG COMP)
4. Magyar Közlöny (Official Gazette of Hungary)
5. Parliament of Hungary, National Legislation Database
6. OECD, Competition and Mergers Resources